Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina

Aim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative contraindications to beta-adrenoblockers (BAB).Material and...

Full description

Bibliographic Details
Main Author: E. V. Kuleshova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2009-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1849